• Inhibiting Inflammation-promoting Enzyme Slows Lung Tissue Scarring, Mouse Study Shows
  • I’ve Lost a Lot But I’m Still Thankful
  • U.S. and Canadian Study Identifies Signaling Pathway That Promotes Lung Scarring
  • Real-world Clinical Data Back Envisia Genomic Classifier’s Potential for IPF Diagnoses
  • Seeking Palliative Care
  • Pain and IPF: What’s the Deal?
  • OFEV Slows Progression of Fibrosis, Lung Imaging in Phase 3b Trial Shows
  • The Impact of a Stranger’s Kindness
  • ATS Foundation and Boehringer Ingelheim Establish Fellowship for Pulmonary Fibrosis Research
  • Esbriet’s Efficacy in Severe IPF Seen to Diminish 6-12 Months After Treatment’s Start, Study Shows
  • Wrestling with the End Stage of Pulmonary Fibrosis
  • Esbriet Reduces Cough in Patients with Idiopathic Pulmonary Fibrosis, Dutch Study Shows